SCHEMBL3765286

SCHEMBL3765286

CCOc1ccc(CC(=O)N2CCN(CC(=O)N3CCN(C4CCC4)CC3)CC2)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
ATM Q13315 1/20 0.53
HTT P42858 2/20 0.49
GFER P55789 1/20 0.48
KDM4E B2RXH2 6/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
GAA P10253 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
TSHR P16473 1/20 0.45
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2C9 P11712 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RAB9A P51151 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3780606 0.93 HTT (0.57) ALDH1A1KMT2AMEN1ATMHTT
SCHEMBL3768296 0.84 KMT2A (0.49) ALDH1A1KMT2AMEN1KDM4EHSD17B10
SCHEMBL3777237 0.81 SMN1; SMN2 (0.64) ALDH1A1KMT2AGFERKDM4EHPGD
SCHEMBL3770296 0.81 NPSR1 (0.57) ALDH1A1KDM4EHPGDHSD17B10L3MBTL1
SCHEMBL3767678 0.80 KMT2A (0.53) ALDH1A1KMT2AMEN1HTTKDM4E
SCHEMBL3770061 0.80 SIGMAR1 (0.63) ALDH1A1KMT2AMEN1KDM4EGAA
SCHEMBL3772095 0.80 SMN1; SMN2 (0.52) ALDH1A1KMT2AMEN1HTTKDM4E
SCHEMBL3767694 0.79 ALDH1A1 (0.52) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL3774233 0.79 RAB9A (0.57) ALDH1A1KMT2AMEN1KDM4EHSD17B10
SCHEMBL3761199 0.79 ALDH1A1 (0.64) ALDH1A1KMT2AKDM4EHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 ALDH1A1 1210/4885KMT2A 242/4885MEN1 3270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.